A new study provides good evidence that the human papillomavirus (HPV) vaccine may be achieving its goal of slashing ra ...

Cervical cancer deaths have plunged dramatically among women under age 25, and researchers at MUSC Hollings Cancer Center ...

"The HPV vaccine prevents cervical cancer by protecting against the high-risk HPV types," cancer researcher Ashish A.

Vaccination of 27- to 45-year-olds against HPV is less cost-effective than vaccination of younger persons (aged 9 to 26 years).

Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight ...

According to its latest financial report, in the first three quarters, Beijing-based Wantai Biopharm, a major HPV vaccine ...

Deaths from cervical cancer are plummeting among young women in the US, and scientists think we have a single vaccine to ...

The Supervisory Councillor for Health Idemili North Local Government Area (INLGA), Dr. Nkem Okeke, Director INLGA Health ...

A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher ...

Human papillomavirus (HPV) is a common viral infection typically transmitted through intimate contact, primarily during ...

Vaccination against HPV can reduce rates of cervical cancer by up to 90 per cent. In countries where HPV vaccination rates ...

The Philippine Infectious Diseases Society for Obstetrics and Gynecology (PIDSOG) has called on the Department of Health (DOH ...